Zogenix: Zogenix: Q4 Earnings Snapshot
EMERYVILLE, Calif. (AP) _ Zogenix Inc. (ZGNX) on Monday reported a loss of $54.9 million in its fourth quarter. On a per-share basis, the Emeryville, California-based company said it had a loss of 98 cents.
Read full article »
Zogenix is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases.
Read more